Cognetivity Looks To Raise $3.0 Million To Fund US Expansion

Cognetivity Neurosciences (CSE: CGN) is looking to close out the year with a capital raise. The firm last night indicated it intends to conduct a non-brokered private placement for gross proceeds of $3.0 million.

The financing will see the company sell roughly 5.5 million units, with each unit being priced at $0.55 per each. Each unit is set to contain one common share and one half of a purchase warrant, with each warrant valid for a period of three years and containing an exercise price of $0.85 per share.

Proceeds from the offering are to be used to expand the firms operations in the US, customer and technical support, marketing, and general operations.

The financing is currently slated to close by January 31, 2022.

Cognetivity Neuroscience last traded at $0.56 on the CSE.


FULL DISCLOSURE: Cognetivity Neurosciences Ltd is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Cognetivity Neurosciences Ltd on The Deep Dive, with The Deep Dive having full editorial control. We may buy or sell securities in the company at any time. Not a recommendation to buy or sell. We may buy or sell securities in the company at any time. Always do additional research and consult a professional before purchasing a security.

Video Articles

Is Gold’s Bull Market About to Hit Junior Stocks? | Ken Armstrong – Westhaven Gold

Surge Battery Metals: The Nevada North Lithium PEA

Silver @ $36 & We’re Still 200M Oz Short | Paul Andre Huet – Americas Gold and Silver

Recommended

Goliath Resources Closes Out Funding Round With Total Gross Proceeds Of $27.1 Million

Silver47 Kickstarts 4,000 Metre Drill Campaign At Red Mountain Project

Related News

Cognetivity: Developing Tech For Early Detection Of Alzheimer’s – The Daily Dive feat Sina Habibi

For the final episode of The Deep Dive this week, we sit down with Sina...

Friday, May 14, 2021, 01:30:00 PM

Cognetivity’s Brain Health Monitoring App – The Daily Dive

On this Daily Dive episode, Cassandra talks to Dr. Sina Habibi, CEO of Cognetivity Neurosciences...

Friday, November 19, 2021, 03:28:00 PM

Cognetivity Neurosciences Files Patent For System Capable Of Early Detection Of Alzheimer’s Disease

Cognetivity Neurosciences (CSE: CGN) this morning announced that it has filed for a key new...

Tuesday, June 8, 2021, 10:08:19 AM

Cognetivity: Tech For Brain Health Screening – The Daily Dive

Joining us again on The Daily Dive is Dr. Thomas Sawyer, COO of Cognetivity Neurosciences...

Tuesday, June 21, 2022, 01:30:00 PM

Cognetivity: Utilizing AI for Early Alzheimer’s Intervention

Sina Habibi, Co-founder & CEO of Cognetivity Neurosciences (CSE: CGN) sits down with us today...

Wednesday, June 14, 2023, 01:30:00 PM